Dosing & Uses
Vitreoretinal Lymphoma
Pending FDA approval for primary vitreoretinal lymphoma
Next:
Pharmacology
Mechanism of Action
Inhibits dihydrofolic acid reductase; inhibits purine and thymidylic acid synthesis, which in turn interferes with DNA synthesis, repair, and cellular replication; cell cycle specific for S phase of cycle
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
